SEC 13F Intelligence

Mpm Bioimpact LLC / ZYME

Mpm Bioimpact LLC’s Zymeworks Inc Position

Does Mpm Bioimpact LLC own Zymeworks Inc (ZYME)? Yes565.2K shares worth $14M (+1.09% of its 13F portfolio) as of Q1 2026.

Position Value
$14M
Q1 2026
Shares
565.2K
% of Portfolio
+1.09%
Quarters Held
1
currently held

Position History ZYME

Reported value by quarter
Q1 ’26: $14MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026565.2K$14M+1.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of ZYME.